期刊文献+

Ela tablets improve sexual performance in mice with erectile dysfunction caused by repeated restraint stress

艾拉片对重复束缚应激所致勃起功能障碍小鼠的治疗作用
原文传递
导出
摘要 Ela tablets contain an optimized extract of a Chinese herbal prescription. The original prescription has been used to treat erectile dysfunction(ED), while the detailed indications and specific treatment mechanisms of Ela tablets remain unclear. In the present study, we aimed to investigate whether Ela tablets could protect mice from ED caused by repeated restraint stress and to explore the possible mechanisms. Mice were restrained daily in centrifuge tubes with venting holes for 14 consecutive days and administered Ela tablets at 1 h before restraining. On the 14 th night, mating experiments were conducted. Thereafter, blood, testicular, and penile samples were collected. Serum testosterone levels were measured using a kit. Testicular tissue morphology was observed by H&E staining. The PDE5 expression in the corpus cavernosum was measured by Western blotting analysis. The results indicated that Ela tablets significantly shortened the sexual arousal time, increased the number of sexual encounters, maintained the normal morphology of testicular tissue, increased the serum testosterone levels, and decreased the PDE5 expression in the corpus cavernosum. Our data showed that Ela tablets elicited protective effects on the sexual ability of mice exposed to repeated restraint stress. Moreover, the underlying mechanism was related to the preservation of testicular tissue morphology, maintenance of testosterone levels, and inhibition of penile PDE5 expression. 艾拉片是由经典维医方药Majun Mupakhi Ela优化提取制备得到的。该方一直用于阳痿的治疗,但艾拉片的具体适应证和治疗机制尚不清楚。本研究拟探讨艾拉片对重复束缚应激所致勃起功能障碍(ED)小鼠的保护作用及其可能机制。每天将小鼠置于束缚盒中连续14天,并在束缚前1小时给予艾拉片。第14日晚进行交配实验。此后,收集血液、睾丸和阴茎样本,测定血清睾酮水平,HE染色观察睾丸组织形态,免疫印迹法检测磷酸二脂酶5(PDE5)在海绵体中的表达变化情况。结果表明,艾拉片能显著缩短性唤起时间,增加性接触次数,维持睾丸组织的正常形态,提高血清睾酮水平,降低阴茎海绵体PDE5的表达。综上,艾拉片对重复束缚应激小鼠的性能力具有保护作用,其机制与保护睾丸组织形态、维持睾酮水平及抑制阴茎PDE5表达有关。
作者 Zeyu Gao Jun Chen Ayinuer Reheman Yi Sun Tao Wu Xirali Tursun Xiaoping Pu Haji Akber Aisa Xin Zhao 高泽宇;陈君;阿依努尔·热合曼;孙懿;吴涛;希尔艾力·吐尔逊;蒲小平;阿吉艾克拜尔·艾萨;赵欣(北京大学药学院天然药物及仿生药物国家重点实验室,北京100191;北京大学药学院分子与细胞药理学系,北京100191;中国科学院新疆理化技术研究所干旱区植物资源与化学重点实验室,新疆乌鲁木齐830011;中国科学院大学,北京100039;新疆医科大学维吾尔医学院,新疆乌鲁木齐830011)
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第11期883-894,共12页 中国药学(英文版)
基金 National Major Scientific and Technological Special Project for "Significant New Drugs Development" during the Thirteenth Five-year Plan Period,China (Grant No.2017ZX09101003-009-006) the Major Science and Technology Projects of Xinjiang Uyghur Autonomous Region (Grant No.2016 A03005-3) the Key Laboratory of Plant Resources and Chemistry in Arid Regions Chinese Academy of Sciences (Grant No.2008DP173091-2017-X,2008DP173091-2017-2) the National Natural Science Foundation of China (Grant No.U1603128) the Research and Development of New Ethnic Medicine Varities and Their Innovative Technologies (Grant No.2017ZX009301045)。
关键词 Ela tablets Erectile dysfunction Repeated restraint stress 艾拉片 勃起功能障碍 重复束缚应激
  • 相关文献

参考文献2

二级参考文献2

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部